IDEXX Labs (IDXX) Tops Q1 EPS by 1c; Boosts FY12 EPS Outlook
Tweet
Share
E-mailGet Alerts IDXX Hot Sheet
Price: $556.93 +2.03%
Financial Fact:
Cost of product revenue: 103.91M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Cost of product revenue: 103.91M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
IDEXX Labs (NASDAQ: IDXX) reported Q1 EPS of $0.72, $0.01 better than the analyst estimate of $0.71. Revenue for the quarter came in at $322.7 million versus the consensus estimate of $314.23 million.
IDEXX Labs sees FY2012 EPS of $3.07-$3.12, versus prior guidance of $3.04-$3.10 and the consensus of $3.08. IDEXX Labs sees FY2012 revenue of $1.31-$1.32 million.
For earnings history and earnings-related data on IDEXX Labs (IDXX) click here.
IDEXX Labs sees FY2012 EPS of $3.07-$3.12, versus prior guidance of $3.04-$3.10 and the consensus of $3.08. IDEXX Labs sees FY2012 revenue of $1.31-$1.32 million.
For earnings history and earnings-related data on IDEXX Labs (IDXX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- Bernstein remains bullish on SpaceX but sees challenges in telecom ambitions
- BMO starts chip stocks coverage: Here are its preferred picks
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
